Kajian klinikal Eksim di Texas
11 kajian untuk Eksim sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 102, College Station
- Clinical Site 104, San Antonio
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Arlington
- Novartis Investigative Site, Cypress
- Novartis Investigative Site, Dallas
- dan 2 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06947993First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Texas Dermatology and Laser Specialists, San Antonio
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07527923A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Texas Dermatology and Laser Specialists, San Antonio
Mengambil pesertaFasa 3
Umur 6 hingga 11 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06807268A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Texas Dermatology and Laser Specialists, San Antonio
Mengambil pesertaFasa 3
Umur 2 hingga 11 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06807281Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- Harrison Dermatology, Missouri City
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 89 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07645820A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
- ALS Global, Irving
Mengambil pesertaFasa 2/3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07355075A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Progressive Clinical Research, PA, San Antonio
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 8, Southlake
Mengambil pesertaFasa 2
Umur 18 hingga 74 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07037901A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Dermatology Treatment and Research Center, Dallas
- North Texas Center for Clinical Research, Frisco
- DCT-Stone Oak, LLC dba Discovery Clinical Trials, San Antonio
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mei 2026 · NCT05995964Flourish: Exploring the Early Infant Gut Microbiome
- Seeding Labs INC, Austin
Mengambil pesertaSukarelawan sihat dialu-alukan
0 Months – 3 Months · Semua jantina · Dikemas kini 24 Feb 2026 · NCT07333482Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.